Maker Of Ocular Multivitamins Points To Benefits Of Omega-3 Fatty Acids As Highlighted In Macular Degeneration Prevention Report

PRWeb

VisiVite.com, makers of multivitamins to improve ocular health, points to new report linking high intake of fatty acids associated with 38% reduction in AMD risk; groundbreaking VisiVite Eye Supplement Formula created with omega-3 intake in mind.

(PRWEB) June 27, 2008 -- VisiVite.com, maker of a full range of multivitamins to improve ocular health, points to a new report in the June issue of Archives of Ophthamology, which says that a diet rich in Omega-3 fatty acids -- closely associated with fish such as tuna, salmon, trout and sardines -- can increase the prevention of age-related macular degeneration (AMD). The findings come as the result of a meta-analysis of studies that concludes that there may be a lower risk of developing AMD due to Omega-3 consumption.

The 12-year review encompasses almost 90,000 participants and is authored by researchers affiliated with several international ocular research organizations, including the Centre for Eye Research Australia; Centre for Molecular, Environmental, Genetic and Analytic Epidemiology; University of Melbourne, Melbourne; Singapore Eye Research Institute; Yong Loo Lin School of Medicine, National University of Singapore; Cancer Epidemiology Center, Cancer Council of Victoria

Age-related macular degeneration - characterized by the thinning and atrophy of the inner lining of the eye - is a leading cause of blindness in the elderly. Previous studies have shown a link between Omega-3 fatty acid intake and slowed progression of age-related macular degeneration, but this is the first analysis that suggests a correlation between beneficial fatty acids and pre-onset prevention of AMD.

The ocular health experts at VisiVite.com already produce eye care supplements rich in Omega-3s. VisiVite Premier Ocular Formula No. 2 contains the long-chain fatty acids (docosahexaenoic acid) (DHA) and eicosapentaenoic acid (EPA). The formula is based on the projected findings of the National Eye Institute's AREDS 2 study, the findings of which are due to be released in 2012.

VisiVite produces macular degeneration supplements that can help potential candidates for AMD combat the disease.

About VisiVite.com:
Founded in 2001, VisiVite.com is dedicated to providing customers with state of the art macular degeneration vitamins to lessen the risk of age-related macular degeneration. Their products range from the VisiVite Omega-3 eye supplements and Macular Degeneration Vitamins to Dry Eye Relief Vitamins, and a full range of multivitamins to improve your ocular health. For more information and up-to-the minute AMD news, visit VisiVite.com.

Contact:
VisiVite.com
1-800-427-7660
http://www.visivite.com

###

  • <<
  • >>

Comments